Oncology Central

T-cell immune suppression in patients with hematologic malignancies: clinical implications


The reversion of immune suppression and restoration of T-cell function against leukemia remains a significant clinical challenge. However, the advent of improved antileukemia-specific T-cell induction and the generation of gene-modified T cells has extended cellular immunotherapy to hematological malignancies.

To view restricted content, please:

Leave A Comment